GMAB – genmab a/s - american depositary shares (US:NASDAQ)

News

EPKINLY Trial Results Prompt Price Target Cut for Genmab (GMAB) [Yahoo! Finance]
Grant of Restricted Stock Units and Warrants to Employees in Genmab [Yahoo! Finance]
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $39.00 price target on the stock.
Genmab (CPSE:GMAB) Valuation Check After Epcoritamab Trial Update And DARZALEX Royalty Momentum [Yahoo! Finance]
Genmab: Darzalex Growth Fuels Rally, Upside Is Tight [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com